Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo

Nature

Volumn 443, Issue 7108, 2006, Pages 222-225

  Pellegrini, Manuela ^a   Celeste, Arkady ^a   Difilippantonio, Simone ^a   Guo, Rong ^b   Wang, Weidong ^b   Feigenbaum, Lionel ^c   Nussenzweig, André ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS; CELL CULTURE; CYTOLOGY; DNA; ENZYMES; IMMUNOLOGY; MUTAGENESIS; PATHOLOGY;

ATAXIA TELANGIECTASIA MUTATED (ATM); AUTOPHOSPHORYLATION; CANCER PREDISPOSITION; DOUBLE-STRAND BREAKS (DSB);

PROTEINS;

ATM PROTEIN; SERINE;

BIOMARKER; DNA; PATHOLOGY; PHYSIOLOGY; PROTEIN; RODENT;

ANIMAL EXPERIMENT; ARTICLE; AUTOPHOSPHORYLATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ATAXIA TELANGIECTASIA; MURINAE;

EID: 33748648775     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05112     Document Type: Article

References (30)

1. Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003).
2. Falck, J., Coates, J. & Jackson, S. P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605-611 (2005).
3. You, Z., Chahwan, C., Bailis, J., Hunter, T. & Russell, P. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol. Cell. Biol. 25, 5363-5379 (2005).
4. Yang, Y. & Sharan, S. K. A simple two-step, 'hit and fix, method to generate subtle mutations in BACs using short denatured PCR fragments. Nucleic Acids Res. 31, e80 (2003).
5. Bartkova, J. et al. ATM activation in normal human tissues and testicular cancer. Cell Cycle 4, 838-845 (2005).
6. Ramiro, A. R. et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440, 105-109 (2006).
7. Liu, Q. et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14, 1448-1459 (2000).
8. Zachos, G., Rainey, M. D. & Gillespie, D. A. Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J. 22, 713-723 (2003).
9. -/- mice. Genes Dev. 14, 1439-1447 (2000).
10. Kitagawa, R., Bakkenist, C. J., McKinnon, P. J. & Kastan, M. B. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev. 18, 1423-1438 (2004).
11. Bartek, J., Lukas, C. & Lukas, J. Checking on DNA damage in S phase. Nature Rev. Mol. Cell Biol. 5, 792-804 (2004).
12. Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152-9159 (2004).
13. Kozlov, S., Gueven, N., Keating, K., Ramsay, J. & Lavin, M. F. ATP activates ataxia-telangiectasia mutated (ATM) in vitro. Importance of autophosphorylation. J. Biol. Chem. 278, 9309-9317 (2003).
14. Uziel, T. et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22, 5612-5621 (2003).
15. Carson, C. T. et al. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22, 6610-6620 (2003).
16. Horejsi, Z. et al. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation. Oncogene 23, 3122-3127 (2004).
17. Cerosaletti, K. & Concannon, P. Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm. J. Biol. Chem. 279, 38813-38819 (2004).
18. Costanzo, V., Paull, T., Gottesman, M. & Gautier, J. Mre11 assembles linear DNA fragments into DNA damage signaling complexes. PLoS Biol. 2, E110 (2004).
19. Difilippantonio, S. et al. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nature Cell Biol. 7, 675-685 (2005).
20. Mochan, T. A., Venere, M., DiTullio, R. A. Jr. & Halazonetis, T. D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 63, 8586-8591 (2003).
21. Sun, Y., Jiang, X., Chen, S., Fernandes, N. & Price, B. D. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl Acad. Sci. USA 102, 13182-13187 (2005).
22. Gupta, A. et al. Involvement of human MOF in ATM function. Mol. Cell. Biol. 25, 5292-5305 (2005).
23. Ali, A. et al. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev. 18, 249-254 (2004).
24. Lee, J. H. & Paull, T. T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308, 551-554 (2005).
25. Dupre, A., Boyer-Chatenet, L. & Gautier, J. Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex. Nature Struct. Mol. Biol. 13, 451-457 (2006).
26. Goldstine, J. V. et al. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity. DNA Repair (Amst.) 5, 432-443 (2006).
27. Goodarzi, A. A. & Lees-Miller, S. P. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells. DNA Repair (Amst.) 3, 753-767 (2004).
28. Cerosaletti, K., Wright, J. & Concannon, P. Active role for nibrin in the kinetics of atm activation. Mol. Cell. Biol. 26, 1691-1699 (2006).
29. Kruhlak, M. J. et al. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J. Cell Biol. 172, 823-834 (2006).
30. Andegeko, Y. et al. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276, 38224-38230 (2001).